NCT05747573

A Study to Compare Pharmacokinetics of GB1211

An Open-label, Randomized, Three-period, Crossover Study to Compare the Pharmacokinetics of GB1211 Upon Dosing a Capsule Under Fasting Condition and a Tablet Under Fasting and Fed Conditions in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 13 (actual)
• Sponsor: Galecto Biotech AB · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study is an open label, Randomized, Three-period, Crossover Study to Compare the Pharmacokinetics of GB1211 upon Dosing a Capsule under Fasting Condition and a Tablet under Fasting and Fed Conditions in Healthy Volunteers

Detailed description

This is relative bioavailability and food effect study to enable further clinical development of a tablet formulation of GB1211.

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	GB1211	Hard tablet or capsules for oral use

Timeline

• Start date: 2023-01-03
• Primary completion: 2023-04-10
• Completion: 2023-04-10
• First posted: 2023-02-28
• Last updated: 2023-09-01

Locations

1 site across 1 country: Netherlands